Bibliografia Miteon Plus

BIBLIOGRAFIA

1.         Dominique Turck, Jean-Louis Bresson, Barbara Burlingame, Tara Dean, Susan Fairweather-Tait, Marina Heinonen, Karen Ildico Hirsch-Ernst, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Monika Neuh€auser-Berthold, Gra_zyna Nowicka, Kristina Pentieva, Yolanda Sanz, Alfonso Siani, Anders Sjodin, Martin Stern, Daniel Tome, Marco Vinceti, Peter Willatts, Karl-Heinz Engel, Rosangela Marchelli, Annette Poting, Morten Poulsen, Josef Rudolf Schlatter, Agnes de Sesmaisons and Henk Van Loveren. Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). doi:10.2903/j.efsa.2017.5058.

2.         Wang J, Zhang HJ, Samuel KG, Long C, Wu SG, Yue HY, Sun LL and Qi GH, 2015. Effects of dietary pyrroloquinoline quinone disodium on growth, carcass characteristics, redox status, and mitochondria metabolism in broilers. Poultry Science, 94, 215–225.

3.         He K, Nukada H, Urakami T and Murphy MP, 2003. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochemical Pharmacology, 65, 67–74.

4.         Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM and Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. 2013. Journal of Nutritional Biochemistry, 24, 2076–2084.

5.         Pyrroloquinoline quinone disodium salt in Natural Health ProductsIngredients Database. Health Canada, Natural Health Products Directorate (NHPD). Health Canada, 2016. Chemical Substance – Available online: http://web prod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=12071⟨=eng

6.         M A Paz, R Flückiger, A Boak, H M Kagan, P M Gallop. Specific detection of quinoproteins by redox-cycling staining. J Biol Chem. 1991 Jan 15;266(2):689-92.

7.         R Flückiger, M A Paz, P M Gallop. Redox-cycling detection of dialyzable pyrroloquinoline quinone and quinoproteins. Methods Enzymol. 1995:258:140-9. doi: 10.1016/0076-6879(95)58043-3.

8.         Rucker R, Chowanadisai W and Nakano M. Potential physiological importance of pyrroloquinoline quinone. 2009. Alternative Medicine Review, 14, 268–277.

9.         Koikeda T, Nakano M and Masuda K. Pyrroloquinoline quinone disodium salt improves higher brain function. 2011. Shinryo To Shinyaku [Medical Consultation & New Remedies], 48, 519–527

10.     Krieger D, Kalman D, Feldman S, Samson A and Nader S. The safety of pyrroloquinoline quinone disodium in older adults with self-reported memory loss. 2016. QPS MRA (Miami Research Associates). Confidential manuscript 12 pp.

11.     Yuji Itoh, Kyoko Hine, Hiroshi Miura, Tatsuo Uetake, Masahiko Nakano, Naohiro Takemura, Kaoru Sakatani. Effect of the Antioxidant Supplement Pyrroloquinoline Quinone Disodium Salt (BioPQQ™) on Cognitive Functions.Randomized Controlled Trial. Adv Exp Med Biol. 2016:876:319-325. doi: 10.1007/978-1-4939-3023-4_40.

12.     Hirokatsu Takatsu, Kei Owada, Kouichi Abe, Masahiro Nakano, Shiro Urano. Effect of vitamin E on learning and memory deficit in aged rats. J Nutr Sci Vitaminol (Tokyo). 2009;55(5):389-93. doi: 10.3177/jnsv.55.389.

13.     Kumazawa T, Sato K, Seno H, Ishii A and Suzuki O. Levels of pyrroloquinoline quinone in various foods. 1995. Biochemical Journal, 307(Pt. 2), 331–333.

14.     Houston M.Meta-analysis, metaphysics and mythology: Scientific and clinical perspective on the controversies regarding vitamin E for the prevention and treatment of disease in humans. Journal of the American Nutraceutical Association 2005; Vol. 8 No. 1.

15.     Kooyenga DK, Geller M, Watkins TR, Bierenbaum ML.Antioxidantinduced regression of carotidstenosis overthree-years.Proceedings of the 16th International Congress of Nutrition. Montreal, July 29, 1997.

16.     Theriault A, Chao JT, and Gapor A. Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes. Atherosclerosis 2002; 160 (1): 21-30.

17.     Chao JT, Gapor A, Theriault A.Inhibitory effect of delta-tocotrienol, a HMG CoA reductase inhibitor, on monocyte-endothelial cell adhesion. J. Nutr.Sci.VitaminoL (Tokyo) 2002; 48 (5): 332-337.

18.     Naito Yetal.Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 2005; 180 (1): 19-25.

19.     Rosenfeldt FL et al.Coenzyme Q10 in the treatment of hypertension: A meta-analysis of the clinical trials.J. Hum. Hypertens. 2007; 21(4): 297-306.

20.     M A Newaz, Z Yousefipour, N Nawal, N Adeeb. Nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats: antioxidant protection by gamma-tocotrienol.J. PhysioL PharmacoL 2003; 54 (3): 319-327.

21.     Theriault A, Chao JT, Wang Q, Gapor A, Adeli K.Tocotrienol: a review of its therapeutic potential. Clinical biochemistry 1999; 32.5: 309-319

22.     Sen CK, Khanna S, Roy S.Tocotrienol: the natural vitamin E to defend the nervous system?Ann. NY Acad.Sci. 2004; 1031:127-42.

23.     Khanna S et al.Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005; 36 (10): 2258-2264

24.     Aggarwal BA.The role of tocotrienols ininflammatory diseases.Cytokine Research Laboratory, Department of Experimental Therapeutics, The University ofTexas M. D. Anderson Cancer Center, Houston, Texas.

25.     DeBose-Boyd R.Tocotrienol mechanism in cholesterol-lowering. UTSouthwestern Medical Center, Dallas, Texas.

26.     Mizushina Y et al.Inhibitory effect of tocotrienol on eukaryotic DNA polymerase lambda and angiogenesis. Biochem. Biophys. Res.Commun. 2006; 339 (3): 949-955.

27.     Nakagawa K, Shibata A, Yamashita S, Tsuzuki T, Kariya J, Oikawa S, Miyazawa T.In vivo angiogenesis is suppressed by unsaturated vitamin E, tocotrienol.J. Nutr. 2007; 137:1938-1943.

28.     Tan B, Watson RR, Preedy VR.Tocotrienols: Vitamin E beyond Tocopherols.

29.     Huanbiao M.Mevalonate-suppressive tocotrienols for cancer chemoprevention and adjuvant therapy. Department of Nutrition and Food Sciences, Texas Woman's University, Denton, Texas.

30.     Ciffolilli S, Legnaioli S, Piroddi M, Pierpaoli E, Provinciali M, Galli F. On the superiority ofhypomethyl (delta- and gamma-) tocotrienols as anticancer agentsin neu-positive breast cancer.

31.     McIntyre BS et al.Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 2000; 224 (4): 292-301.

32.     McAnally JA et al. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo. Exp. Biol. Med. (Maywood) 2007; 232 (4): 523-531.

33.     Nesaretnam K. et al.Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998; 33 (5): 461-469.

34.     Conte C. et al.Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells. Ann. NY Acad.Sci. 2004; 1031, 391-394.

35.     Eitsuka T, Nakagawa K, and Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem. Biophys. Res. Commun. 2006; 348 (1): 170-175

36.     Malafa MP, Sebti S. Delta-tocotrienol treatment and prevention of pancreatic cancer. 2008. Lee Moffitt Cancer Center & Research lnstitute, University of South Florida (Tampa).

37.     Malafa MP, Sebti S. Delta-tocotrienol treatment and prevention of pancreatic Cancer. 2008. Lee Moffitt Cancer Center & Research Institute, University of South Florida (Tampa).

38.     Sakai M et al. Apoptosis induction by gamma-tocotrienol in human hepatoma Hep3B cells. J. Nutr. Biochem. 2006; 17 (10): 672-676.

39.     Kline K, Yu W, Sanders BG.Vitamin E: mechanisms of action as tumor cell growth inhibitors. J. Nutr. 2001; 131 (1): 161S-163S.

40.   Song BL, De Bose-Boyd RA. lnsig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by delta- and gamma-tocotrienols. J. Biol. Chem. 2006; 281 (35): 25054-25061.

41.     Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA.Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens. Lipids 2006; 41:453-461.

42.    McIntyre BS et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells.Proc. Soc. Exp. Biol. Med. 2000; 224 (4): 292-301.

43.     Fladerer JP, Grollitsch S. Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Current Cardiology Reports (2023) 25:1759–1767. doi: 10.1007/s11886-023-01992-6.

44.     Wenxu Pan, Guiquan Zhou, Meiling Hu, Gaoshan Li, Mingle Zhang, Hao Yang, Kunyan Li, Jingwei Li, Ting Liu, Ying Wang, Jun Jin.Coenzyme Q10 mitigates macrophage mediated inflammation in heart following myocardial infarction via the NLRP3/IL1β pathway.- BMC Cardiovasc Disord. 2024 Oct 5;24(1):537. doi: 10.1186/s12872-024-04195-1.

45.     Elena I. Kalenikova, Evgeniya A. Gorodetskaya, Oxana V. Povarova, Oleg S. Medvedev. Prospects of Intravenous Coenzyme Q10 Administration in Emergency Ischemic Conditions. Life (Basel). 2024 Jan 17;14(1):134. doi: 10.3390/life14010134.

46.     Sophia Emmons-Bell, Catherine Johnson, Gregory Roth.Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022 Aug 11;108(17):1351-1360. doi: 10.1136/heartjnl-2021-320131.

47.     Tian G, Sawashita J, Kubo H, et al. Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice. Antioxid Redox Signal 2014;20(16):2606-2620.

48.     Kishi T, Watanabe T, Folkers K. Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q10-enzymes by clinically used adrenergic blockers of beta-receptors. Res Commun Chem Pathol Pharmacol 17:157-164 (1977).

49.     Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221(2):311-316.

50.     Mortensen, S. A., Rosenfeldt, F., Kumar, A., Dolliner, P., Filipiak, K. J., Pella, D., & Littarru, G. P. (2014). The effect of Coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double blind trial. JACC. Heart Failure, 2(6), 641-649.

51.     McMurray JJ, Dunselman P, Wedel H, et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure). J Am Coll Cardiol. 2010;56(15):1196-1204.

52.     Tran MT, Mitchell TM, Kennedy DT, Giles JT. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy. 2001;21(7):797-806.

53.     Mantle D, Dybring A. Bioavailability of coenzyme Q10: An overview of the absorption process and subsequent metabolism. Antioxidants. 2020;9(5):1–12.

54.     Masenga S, Kabwe L, Chakulya M, Kirabo A. Mechanisms of Oxidative Stress in Metabolic Syndrome. Int J Mol Sci [Internet]. 2023;26. Available from: https://pubmed.ncbi.nlm.nih.gov/37175603/.

55.     Tomasetti M, Alleva R, Solenghi MD, Littarru GP. Distribution of antioxidants among blood components and lipoproteins: Significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. BioFactors. 1999;9(2–4).

56.     Bhagavan HN, Chopra RK. Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006;40(5).

57.     Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). Biofactors. 2008.

58.     Tippairote T, Bjørklund G, Gasmi A, Semenova Y, Peana M, Chirumbolo S, et al. Combined supplementation of Coenzyme Q10 and other nutrients in specific medical conditions. Nutrients. 2022;14(20):1–23.

59.     Pravst I, Žmitek K, Žmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr. 2010;50(4).

60.     Bhagavan HN, Chopra RK. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Vol. 7, Mitochondrion. 2007.

61.     De Barcelos IP, Haas RH. CoQ10 and aging. Biology (Basel). 2019;8(2).

62.     Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, et al. Characterization of a polymorphism in NAD(P)H: Quinone oxidoreductase (DT-diaphorase). Br J Cancer. 1997;75(1).

63.     Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H: quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms.Chem Biol Interact. 2000;129(1–2):77–97.

64.     Siege D, McGuinness S, Winski S, Ross D. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H: quinone oxidoreductase 1.Pharmacogenetics. 1999

65.     Saini R. Coenzyme Q10: The essential nutrient.Vol. 3, Journal of Pharmacy and Bioallied Sciences. 2011. 

66.     Weis M, Mortensen SA, Rassing MR, Møller-Sonnergaard J, Poulsen G, Rasmussen SN. Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteers.Mol Aspects Med. 1994;15 (SUPPL. 1). 

67.     Taheri Y, Quispe C, Herrera-Bravo J, et al. Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications. Evid Based Complement Alternat Med. 2022;2022:4024331. Published 2022 Feb 24. doi:10.1155/2022/4024331.

68.    Kregiel D, Pawlikowska E, Antolak H.Urtica spp.: Ordinary Plants with Extraordinary Properties.Molecules. 2018;23(7):1664. Published 2018 Jul 9. doi:10.3390/molecules23071664.

69.     Roschek B Jr, Fink RC, McMichael M, Alberte RS. Nettle extract (Urtica dioica) affects key receptors and enzymes associated with allergic rhinitis.Phytother Res. 2009 Jul;23(7):920-6. doi: 10.1002/ptr.2763. PMID: 19140159.

70.     Zouari Bouassida K, Bardaa S, Khimiri M, et al. Exploring the Urtica dioica Leaves Hemostatic and Wound-Healing Potential.Biomed Res Int. 2017;2017:1047523. doi:10.1155/2017/1047523.

71.     Rutto LK, Xu Y, Ramirez E, Brandt M. Mineral Properties and Dietary Value of Raw and Processed Stinging Nettle (Urtica dioica L.).Int J Food Sci. 2013;2013:857120. doi:10.1155/2013/857120.

72.     Ghorbanibirgani A, Khalili A, Zamani L. The efficacy of stinging nettle (urtica dioica) in patients with benign prostatic hyperplasia: a randomized double-blind study in 100 patients.Iran Red Crescent Med J. 2013;15(1):9-10. doi:10.5812/ircmj.2386.

73.     Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms.Int J Mol Sci. 2018 Mar 7;19(3):765. doi: 10.3390/ijms19030765. PMID: 29518971; PMCID: PMC5877626.

74.    Hwang PS, Machek SB, Cardaci TD, Wilburn DT, Kim CS, Suezaki ES, Willoughby DS. Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men. J Am Coll Nutr. 2020 Aug;39(6):547-556. doi: 10.1080/07315724.2019.1705203. Epub 2019 Dec 20. PMID: 31860387.

75.   Naveed M, Tariq K, Sadia H, Ahmad H, Mumtaz AS. The Life History of Pyrroloquinoline Quinone (PQQ): A Versatile Molecule with novel Impacts on Living Systems. Molecular Biology 1(1): 00005. DOI: 10.15406/ijmboa.2016.01.00005

76.  Xie T, Zhang Z, Feng M, Kong L. Current study on Pyrroloquinoline quinone (PQQ) therapeutic role in neurodegenerative diseases. Mol Biol Rep. 2025 Apr 15;52(1):397. doi: 10.1007/s11033-025-10491-6. PMID: 40234255.

77.      Stites T. E., Mitchell A. E., Rucker R. B. (2006). Physiological importance of quinoenzymes and the O-quinone family: the case of pyrroloquinoline quinone. The Journal of Nutrition, 136(10), 2827–2834.

78.      Chowanadisai W. et al. (2010). Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1α expression. The Journal of Biological Chemistry, 285(1), 142–152.

79.      Littarru G. P. & Tiano L. (2007).Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology, 37(1), 31–37.

80.      Nakano M. et al. (2013).Effects of coenzyme Q10 and pyrroloquinoline quinone on cognitive function in the elderly. Journal of Nutritional Science and Vitaminology, 59(4), 351–355.